45.10USD-4.12%Mkt Cap: 2.24B $P/E: 73.931d ago
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offe…
Industry Peers
Medical Care Facilities$85.57BUSDP/E 13.3
$25.55BUSDP/E 15.6
$17.16BUSDP/E 10.4
$15.02BUSDP/E 22.5
$12.33BUSDP/E 12.9
$11.16BUSDP/E 19.3
$10.10BUSDP/E 28.2
$9.29BUSDP/E 6.4
$7.22BUSDP/E 29.4
$6.66BUSDP/E 27.4
$4.31BUSDP/E 188.2
$4.05BUSDP/E 22.8
$3.65BUSD
$3.21BUSDP/E 38.0
$3.51BUSDP/E 28.5
$3.47BUSDP/E 17.3
$3.09BUSD
$2.46BUSD
$2.56BUSDP/E 48.1
$2.57BUSDP/E 27.4
$2.26BUSD
$2.18BUSD
$2.16BUSDP/E 12.8
$2.16BUSDP/E 8.2
$2.12BUSDP/E 21.0
$2.02BUSD
$1.92BUSD
$1.79BUSDP/E 48.4
$1.72BUSDP/E 26.3
$1.56BUSDP/E 19.5
$1.89BUSDP/E 14.0
$1.56BUSDP/E Infinity
$1.61BUSD
$1.46BUSDP/E 10.9
$1.45BUSDP/E 48.5
$1.41BUSDP/E 1216.0
$1.31BUSD
$1.27BUSD
$1.33BUSD
$1.11BUSDP/E 16.9
$1.13BUSDP/E 12.0
$1.13BUSDP/E 148.4
$1.01BUSDP/E 12.0
$962.11MUSDP/E 55.8
$960.42MUSDP/E 22.0
$949.24MUSDP/E 54.5
$788.66MUSDP/E 38.5
$729.70MUSDP/E 7.0
$525.91MUSDP/E 22.8
$525.91MUSD
$476.30MUSDP/E 1.0
$452.53MUSD
$427.74MUSD
$401.76MUSDP/E 15.2
$336.36MUSD
$285.00MUSDP/E 15.3
$293.47MUSD
$262.54MUSDP/E 6.9
$214.78MUSDP/E 6.8
$229.55MUSDP/E 14.4
$174.88MUSDP/E 28.2
$154.62MUSD
$164.00MUSD
$154.79MUSDP/E 7.8
$148.68MUSDP/E 1.5
$136.08MUSDP/E 70.4
$128.58MUSDP/E 100.2
$88.13MUSD
$84.62MUSDP/E 5.5
$77.79MUSDP/E 23.2
$63.03MUSD
$57.22MUSD
$26.19MUSDP/E 64.0
$24.16MUSDP/E Infinity
$20.63MUSD
$14.83MUSD
$10.78MUSD
$9.74MUSD
$1.55MUSD
JNH
Jack Nathan Medical Corp.$634.3KUSD
$513.3KUSDP/E Infinity
$202.1KUSD
$82.5KUSD
$76.9KUSD
$1.6KUSD
Indicators:|
| Headline | Source | Time |
|---|---|---|
Yesterday | ||
 Astrana Health (ASTH) Stock Looks Fully Valued Following Its 87% Run Astrana Health stock has surged 86.5% year to date, yet the company still carries a low overall value score and screens as expensive on traditional valuation multiples, which raises the question of how much of the recent optimism is already reflected in the price. The 86.5% year to date gain points to strong momentum, but also means new buyers are paying a much higher entry price than they could earlier in the year. Recent shared savings performance and revenue growth can support high... | ||
This week | ||
 2 Reasons to Like ASTH and 1 to Stay Skeptical The past six months have been a windfall for Astrana Health’s shareholders. The company’s stock price has jumped 79%, hitting $49.01 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move. | ||
Older | ||